These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction. Van Lent J; Verstraelen P; Asselbergh B; Adriaenssens E; Mateiu L; Verbist C; De Winter V; Eggermont K; Van Den Bosch L; De Vos WH; Timmerman V Brain; 2021 Sep; 144(8):2471-2485. PubMed ID: 34128983 [TBL] [Abstract][Full Text] [Related]
9. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review. Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294 [TBL] [Abstract][Full Text] [Related]
10. Energy metabolism and mitochondrial defects in X-linked Charcot-Marie-Tooth (CMTX6) iPSC-derived motor neurons with the p.R158H PDK3 mutation. Perez-Siles G; Cutrupi A; Ellis M; Screnci R; Mao D; Uesugi M; Yiu EM; Ryan MM; Choi BO; Nicholson G; Kennerson ML Sci Rep; 2020 Jun; 10(1):9262. PubMed ID: 32504000 [TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX). Son D; Kang PJ; Yun W; You S Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541 [TBL] [Abstract][Full Text] [Related]
12. Modeling Drug-Induced Neuropathy Using Human iPSCs for Predictive Toxicology. Ohara R; Imamura K; Morii F; Egawa N; Tsukita K; Enami T; Shibukawa R; Mizuno T; Nakagawa M; Inoue H Clin Pharmacol Ther; 2017 Jun; 101(6):754-762. PubMed ID: 27859025 [TBL] [Abstract][Full Text] [Related]
14. Gene Repair of iPSC Line with GARS (G294R) Mutation of CMT2D Disease by CRISPR/Cas9. Lu PJ; Zhang P; Liu YC; Jing N; Guo YN; Wang PS; Su LL; Guo Q; Ma Q; Xu YM; Zhang ST Curr Med Sci; 2023 Apr; 43(2):261-267. PubMed ID: 36932303 [TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B). Son D; Kang PJ; Yun W; You S Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895 [TBL] [Abstract][Full Text] [Related]
16. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1. Zhai J; Lin H; Julien JP; Schlaepfer WW Hum Mol Genet; 2007 Dec; 16(24):3103-16. PubMed ID: 17881652 [TBL] [Abstract][Full Text] [Related]
17. Neuronal modeling of alternating hemiplegia of childhood reveals transcriptional compensation and replicates a trigger-induced phenotype. Snow JP; Westlake G; Klofas LK; Jeon S; Armstrong LC; Swoboda KJ; George AL; Ess KC Neurobiol Dis; 2020 Jul; 141():104881. PubMed ID: 32348881 [TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the GDAP1 gene is associated with autosomal recessive Charcot-Marie-Tooth disease in an Amish family. Xin B; Puffenberger E; Nye L; Wiznitzer M; Wang H Clin Genet; 2008 Sep; 74(3):274-8. PubMed ID: 18492089 [TBL] [Abstract][Full Text] [Related]
19. Auditory Neuropathy Spectrum Disorder Progressing with Motor and Sensory Neuropathy Caused by an ATP1A1 Variant. Okumura G; Nakamura K; Seyama R; Uchiyama Y; Shinagawa J; Nishio S; Ikeda J; Takayama S; Kodaira M; Kosho T; Takumi Y; Matsumoto N; Sekijima Y Intern Med; 2024 Apr; 63(7):1005-1008. PubMed ID: 37558483 [TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of long isoform sequencing and functional data identifies distinct cortical layer neuronal subtypes derived from human iPSCs. Zehra B; Mohamed N; Farhat A; Bru-Mercier G; Satsangi D; Tambi R; Kamarudheen R; Kumail M; Khalil R; Pessia M; D'Adamo MC; Berdiev BK; Uddin M J Neurophysiol; 2024 Sep; 132(3):653-665. PubMed ID: 38988287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]